Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BLOC-1 related complex subunit 8 (BORCS8) is a small, highly conserved protein component of the BLOC-one-related complex (BORC), a multiprotein complex of eight subunits (BORCS1–8) that associates with the cytosolic face of lysosomes. BORC recruits the ARL8 GTPase to the lysosomal membrane and couples lysosomes to microtubule plus-end-directed motor proteins (such as kinesin-1 and kinesin-3), thereby driving lysosome transport toward the cell periphery in most cell types and distal axon in neurons. BORCS8 is essential for the stability and assembly of the BORC complex; its loss destabilizes other subunits, affecting lysosome distribution and impacting processes like autophagy and cell migration. Pathogenic biallelic variants in BORCS8 cause a severe, early-onset neurodegenerative disorder characterized by global developmental delay, intellectual disability, hypotonia, muscle wasting, optic atrophy, and brain abnormalities, underscoring its role in neuronal health and lysosomal function. BORCS8 is not known to be a direct therapeutic target, receptor, enzyme, or transporter, but appears critical for normal lysosome dynamics and neuronal maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BLOC-1 related complex subunit 8 (BORCS8).